A decision framework for treating chronic immune thrombocytopenia with thrombopoietin receptor agonists

Journal of Comparative Effectiveness Research
Mike DolphAndrew Briggs

Abstract

Aim: Eltrombopag and romiplostim are comparable second-line therapies in chronic immune thrombocytopenia. Treatment decisions are made in different contexts. A framework was created to outline decision pathways for physicians and payers. Materials & methods: The costs of drugs, administration, routine care, bleeding, other adverse events and mortality were included in the year-long calculation of total costs from a US private payer perspective. Treatment parameters and outcome data were obtained from relevant clinical trials. Results: The total cost per year, per patient of eltrombopag was US$51,000 versus US$76,000 for romiplostim. Drug costs and costs associated with bleeding-related events were the main drivers of cost difference. Conclusion: This framework facilitates decision-making in the management of chronic immune thrombocytopenia with eltrombopag and romiplostim.

References

Jul 28, 2006·Journal of Thrombosis and Haemostasis : JTH·J B Segal, N R Powe
Aug 2, 2006·Journal of Thrombosis and Haemostasis : JTH·J N George
Nov 5, 2009·European Journal of Haematology. Supplementum·Marc Michel
Aug 26, 2009·American Journal of Hematology·Mark D DaneseJoseph Mikhael
Oct 20, 2009·Current Medical Research and Opinion·Mansoor N SalehKelly M Grotzinger
Nov 12, 2010·The New England Journal of Medicine·David J KuterDietmar P Berger
Feb 11, 2011·The New England Journal of Medicine·Drew Provan, Adrian C Newland
Feb 4, 2014·International Journal of Technology Assessment in Health Care·Katy CooperRon Akehurst
Jan 30, 2015·The Journal of Physical Chemistry. a·Tyler Y Takeshita, Thom H Dunning
Oct 27, 2015·Advances in Therapy·Drew Provan, Adrian C Newland
Mar 5, 2016·BMJ : British Medical Journal·Peter B BachLeonard B Saltz
Aug 28, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Rachel AllenBethan Woods

❮ Previous
Next ❯

Software Mentioned

AnalySource
RAISE
Excel
Nplate

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.